Phase 3 Readout~month
Phase 3 Topline: Bumetanide vs. Furosemide for Adults Hospitalized With Cirrhosis: the BUFF Trial
- Company
- JOHNSON & JOHNSON (JNJ)
- Drug
- cirrhosis
- Indication
- Cirrhosis
Other upcoming events for JNJ
Track this catalyst and more
Get real-time alerts, AI-powered analysis, and full catalyst coverage.